Preclinical characterization of a Fab-like CD3/CLDN18.2 XFab® bispecific antibody against solid tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preclinical characterization of a Fab-like CD3/CLDN18.2 XFab® bispecific antibody against solid tumors

Published:2022-11 Issue:6 Volume:227 Page:152283
ISSN:0171-2985
Container-title:Immunobiology
language:en
Short-container-title:Immunobiology

Author:

Xu Guili,Qian Niliang,Liu Yujie,Li Hongjie,Yang Cuima,Wang Jingjing,Wang Fuyu,Chen Liting,Bai Guijun,Xu Qinzhi,Pan Xiujie,Gao Xin

Publisher

Elsevier BV

Subject

Hematology,Immunology,Immunology and Allergy

Reference28 articles.

1. Determining kinetics and affinities of protein interactions using a parallel real-time label-free biosensor, the Octet;Abdiche;Anal. Biochem.,2008

2. The role of Blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia;Benjamin;Ther. Adv. Hematol.,2016

3. Laboratory issues in gene therapy and emicizumab;Bowyer;Haemophilia,2021

4. Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine release;Dang;J. Immunother. Cancer,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid and convenient screening method based on single-chain variable fragments for the detection of restricted monensin in chicken muscle;International Journal of Biological Macromolecules;2024-10

2. Claudin 18.2 as a New Biomarker in Gastric Cancer—What Should We Know?;Cancers;2024-02-05

3. Antibody-mediated targeting of Claudins in cancer;Frontiers in Oncology;2024-02-02

4. Claudin-18.2 mediated interaction of gastric Cancer cells and Cancer-associated fibroblasts drives tumor progression;Cell Communication and Signaling;2024-01-10

5. One-Step Platform for Maduramicin and Salinomycin Detection Based on Bispecific Monoclonal Antibody and Interpretation of Molecular Recognition Mechanism;Journal of Agricultural and Food Chemistry;2023-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3